Back

Impact of multidisciplinary cardiometabolic clinics on cardiovascular risk management and therapeutic optimization in patients with type 2 diabetes mellitus

31 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (2) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Evangelos Oikonomou

National & Kapodistrian University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Insulin resistance in individuals without type 2 diabetes is associated with large arteries stiffening
Mrs M. Nankinova (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Association between pcsk9 levels and diabetes risk: a community-based nested case-control study
Mr Z. Qiu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Associations of serum insulin level trajectories with cardiovascular disease incidence and mortality: a two-decade population-based study
Doctor F. Esmaeili (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of different clinic models on cardiometabolic risk optimisation and cardioprotective therapies in post myocardial infarction patients with type 2 diabetes
thumbnail
Congress Presentation
An innovative multi-disciplinary cardiometabolic clinic for patients with atherosclerotic cardiovascular disease leads to improved risk factor optimisation compared to standard care
thumbnail
Congress Presentation
Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources